Heart Failure and Cardiomyopathies Flashcards

1
Q

Pathophysiology of Heart Failure:

1) ___ overload
2) ___ overload
3) Myocardial ___
4) Myocardial ___
5) Restricted ___

A

1) Pressure
2) Volume
3) Ischemia/infarction
4) Inflammatory disease
5) diastolic filling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adaptive Response to Failure:

  • Frank-starling relationship
  • Activation of ___
  • Alterations in inotropic state, HR and afterload
  • ___ responses

*When mechanisms become maladaptive it leads to?

A
  • SNS
  • Humoral-mediated
  • myocardial remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Activation of SNS: *Increases in ___

  • Arteriolar constriction: -maintains BP despite decrease in ___
  • redirects blood flow to ___ and ___
  • Venous constriction: -increases ___
  • ___ maintained by Frank-Starling relationship
  • ___ release due to decrease in renal BF; this increases blood volume and ultimately CO by sodium and water retention
A
  • HR
  • CO
  • coronary and cerebral system
  • preload
  • CO
  • Renin-angiotensin aldosterone release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Other Adaptive Responses (HF):

  • To increase CO: increase in ___, reduction in ___, increase in ___
  • To promote BP control and protect from the effects of volume and pressure overload: Release of __ and ___
  • Diuresis -Natriuresis -Vasodilation -anti-inflammation
  • inhibition of RAS and SNS and cardiac remodeling
A
  • contraction velocity
  • afterload
  • HR
  • atrial NP and B type natriuretic peptide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Myocardial Remodeling:

  • Myocardial ___
  • Myocardial ___ and ___
  • Increased ___ deposition
  • Myocardial ___
  • ___ formation
A
  • hypertrophy
  • dilation and wall thinning
  • interstitial collagen deposition
  • fibrosis
  • Scar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical Features of Heart Failure:

  • ___ (orthopnea/orthopneic cough, paroxysmal nocturnal dyspnea)
  • ___ due to dilation
  • ___ at rest
  • ***Name 9 other s/s
A
  • dyspnea
  • Atrial fibrillation
  • weakness at rest
  • fatigue -oliguria -edema -tachycardia -S3 gallop
  • tachypnea -lung rales -hypotension -JVD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Heart Failure in a nutshell:
Decrease ___ –> ___ to increase contractility from stretched muscle fibers –> Increase ___ results in increased cardiac work –> increase ___ and ___ –> ___ falls –> Increase ___ to increase HR and SVR –> ___ falls

A
  • contractility
  • ventricle dilated
  • ventricular radius
  • oxygen consumption and increased cardiac work
  • CO
  • sympathetic outflow
  • Stroke volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of Heart Failure:

  • ACE inhibitors/Angiotensin II receptor blockers
  • Diuretics -Digoxin -Inotropes -Beta Blockers -Nesiritide
  • ___ antagonists
  • ___ therapy
  • ___ pacing
  • Assistive devices
A
  • Aldosterone
  • Vasodilator
  • Biventricular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anesthetic Management of Heart Failure:

  • **The Goal is to prevent and avoid ___:
  • Heart rate = ?
  • Preload = ?
  • Afterload = ?
  • Contractility = ?
A
  • **myocardial depression
  • normal to elevated
  • normal to high
  • low
  • increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anesthetic Management with Heart Failure: (+/- a-line, usually want it)

  • Maintain ___, especially ___
  • Hypotension treated with ___, ___, ___
  • General anesthetic doses may be ___
  • ___ beneficial in decreasing pulmonary congestion
  • ___ ok
  • Avoid ___
A
  • medication therapy, beta blockers
  • ephedrine, phenylephrine, vasopressin
  • decreased
  • positive pressure ventilation
  • regional anesthesia ok
  • fluid overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cardiomyopathies:
___ = Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Left ventricular noncompaction, Glycogen storage disease, Conduction system disease (Lenegre’s Disease), Ion channelopathies-Long QT syndrome, Brugada syndrome, short QT syndrome

A

Genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cardiomyopathies:
*___ = Dilated cardiomyopathy, Primary restrictive nonhypertrophic cardiomyopathy

*___ = Myocarditis (inflammatory cardiomyopathy-viral, bacterial, rickettsial, fungal, parasitic (Chagas’s disease)), Stress cardiomyopathy, Peripartum cardiomyopathy

A
  • Mixed

* Acquired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Hypertrophic Cardiomyopathy:
Pathophysiology = Myocardial hypertrophy
--> Dynamic LV outflow tract \_\_\_ (asymmetric septal hypertrophy, systolic anterior movement of the \_\_\_ and \_\_\_)
--> \_\_\_ dysfunction
--> Myocardial \_\_\_ 
--> Dysrhythmias
A
  • obstruction
  • mitral valve and mitral regurgitation
  • Diastolic
  • Ischemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Signs and Symptoms of Hypertrophic Cardiomyopathy:

6 ??????

A
Angina
Fatigue
Syncope
Tachydysrhythmias
Heart failure
sudden death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypertrophic Cardiomyopathy Events Increasing Outflow Obstruction: Digitalis, Vasodilators, + Pressure Ventilation

  • Beta adrenergic ___
  • ___ preload
  • Volume?
  • Heart rate?
  • BP? -___ afterload -___ myocardial contractility
A
  • stimulation (catecholamines)
  • Decreased preload
  • Hypovolemia
  • Tachycardia
  • Hypotension
  • Decreased afterload
  • Increased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inability to adequately fill or empty the ventricle?

Due to: CAD, Cardiomyopathy, Valve abnormalities, HTN, Diseases of the pericardium, pulmonary HTN (cor pulmonale)

A

Heart Failure

17
Q

Hypertrophic Cardiomyopathy Events Decreasing Outflow Obstruction: Volatile anesthetics, Calcium entry blockers, alpha adrenergic stimul.

  • Beta adrenergic ___
  • ___ preload
  • Volume?
  • Heart rate?
  • BP? -___ afterload -___ myocardial contractility
A
  • blockade
  • Increased
  • Hypervolemia
  • Bradycardia
  • HTN
  • Increased
  • Decreased
18
Q

Treatment of Hypertrophic Cardiomyopathy:

  • Treatment of underlying cause of Cardiomyopathy
  • ___
  • ___
A

Beta blockers

Calcium channel blockers

19
Q

Anesthetic Management of Patients with Hypertrophic Cardiomyopathy:

  • Minimize ???
  • ___ myocardial contractility depression
  • ___ effects on preload and afterload
A
  • LV outlet obstruction
  • mild
  • minimal effects
20
Q

Anesthetic Management of Pt. with Hypertrophic Cardiomyopathy:

  • A-line -___ good
  • Treat hypotension with ___ (___) and ___!!!
  • ___ are contraindicated
  • Prompt replacement of ___ and ___
  • Avoid ___
  • Maintain ___
A
  • Volatile anesthetics good
  • alpha adrenergic agonists (phenylephrine) and VOLUME
  • Beta adrenergic agonists
  • blood and fluids
  • vasodilators
  • NSR
21
Q

Myocardial disease with LV or biventricular dilation, systemic dysfunction, and normal LV thickness?

A

Dilated Cardiomyopathy

22
Q

Dilated Cardiomyopathy Anesthesia: The goal is to prevent and avoid ?

1) Heart rate = ?
2) Preload = ?
3) Afterload = ?
4) Contractility = ?

A

Myocardial Depression

1) normal to elevated
2) normal to high
3) low
4) increase

23
Q

Right ventricular enlargement with hypertrophy and/or dilation that may progress to right heart failure?

*Caused by ___ and ___

A

Cor pulmonale

  • pulmonary hypertension
  • chronic alveolar hypoxia
24
Q

Cor Pulmonale Management:

  • Eliminate any ?
  • Reverse ___
  • Improve ___
  • Maintain good ___, ___ and ___
  • Correct ___
A
  • infection
  • bronchospasm
  • expectoration
  • oxygenation, hydration and lung mechanics
  • electrolyte imbalance
25
Q

Cor Pulmonale Management: -Oxygenation

  • Avoid ___
  • Depth of anesthetic (keep deep to avoid ___)
  • Bronchodilator effects of ___
  • A-line
  • ___ for monitoring RV function
  • ___ should be avoided, otherwise ok
A
  • Histamine releasers
  • bronchospasm
  • inhalational agents
  • TEE
  • High level block with regional